BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16929165)

  • 1. Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.
    Atanackovic D; Blum I; Cao Y; Wenzel S; Bartels K; Faltz C; Hossfeld DK; Hegewisch-Becker S; Bokemeyer C; Leuwer R
    Cancer Biol Ther; 2006 Sep; 5(9):1218-25. PubMed ID: 16929165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
    Atanackovic D; Arfsten J; Cao Y; Gnjatic S; Schnieders F; Bartels K; Schilling G; Faltz C; Wolschke C; Dierlamm J; Ritter G; Eiermann T; Hossfeld DK; Zander AR; Jungbluth AA; Old LJ; Bokemeyer C; Kröger N
    Blood; 2007 Feb; 109(3):1103-12. PubMed ID: 17023585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
    Kienstra MA; Neel HB; Strome SE; Roche P
    Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
    Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
    Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
    Piotti KC; Scognamiglio T; Chiu R; Chen YT
    Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
    Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
    Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.
    Chen YT; Panarelli NC; Piotti KC; Yantiss RK
    Cancer Immunol Res; 2014 May; 2(5):480-6. PubMed ID: 24795360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
    Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
    J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Photodynamic Therapy on the Expression of Cancer/Testis Antigens in Squamous Cell Carcinoma of the Head and Neck.
    Theodoraki MN; Lorenz KJ; Schneider J; Thierauf JC; Spagnoli G; Schuler PJ; Hoffmann TK; Laban S
    Anticancer Res; 2016 Aug; 36(8):3973-82. PubMed ID: 27466502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes.
    Cesson V; Rivals JP; Escher A; Piotet E; Thielemans K; Posevitz V; Dojcinovic D; Monnier P; Speiser D; Bron L; Romero P
    Cancer Immunol Immunother; 2011 Jan; 60(1):23-35. PubMed ID: 20857101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
    Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende C; Dyckhoff G; Boscolo-Rizzo P; Ezic J; Marienfeld RB; Möller P; Völkel G; Kraus JM; Kestler HA; Brunner C; Schuler PJ; Wigand M; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Butt J; Waterboer T; Laban S
    Int J Cancer; 2019 Dec; 145(12):3436-3444. PubMed ID: 31407331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
    Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF
    Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-testis (CT) antigen expression in medulloblastoma.
    Oba-Shinjo SM; Caballero OL; Jungbluth AA; Rosemberg S; Old LJ; Simpson AJ; Marie SK
    Cancer Immun; 2008 Apr; 8():7. PubMed ID: 18426187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
    Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S
    Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
    Jungbluth AA; Antonescu CR; Busam KJ; Iversen K; Kolb D; Coplan K; Chen YT; Stockert E; Ladanyi M; Old LJ
    Int J Cancer; 2001 Oct; 94(2):252-6. PubMed ID: 11668506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
    Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
    Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.